Popular Articles

Innovative Medicines Initiative: 246 Million Euros To Support Public-private Research Cooperation For A Fast Development Of Better Medicines
Today, 15 new research projects aimed at bringing innovative medicines more quickly to the market have been selected to receive 246 million euros from the European Commission and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The projects will foster understanding of health issues such as diabetes, pain, severe asthma and psychiatric disorders while increasing drug safety. They will also help improve the training of researchers and clinicians involved in medicines development. The projects were chosen following the first call for proposals launched within the Innovative Medicines Initiative (IMI), a public-private partnership - so called Joint Technology Initiative- between the European Commission and the pharmaceutical industry. With this selection, IMI has reached a key milestone. This initiative marks the first time that pharmaceutical competitors are pooling their res, together with research organisations, patient groups and other stakeholders in large consortia, in order to develop generic, pre-competitive knowledge. The Commission"s contribution of €110 million is backed up with €136 million provided in-kind from the pharmaceutical industry. The successful projects will now enter into the final negotiation phase.
generic viagra online
Surgeon General Releases Call To Action To Promote Healthy Homes
Statement of Charles D. Connor, American Lung Association President and CEO:
News of the day
Study Finds Noninvasive Blood Test For Liver Fibrosis May Alleviate Need For Liver Biopsies For Some Patients With Chronic Hepatitis C
A study in the June issue of Clinical Gastroenterology and Hepatology, published by Elsevier, demonstrates that the Hepascore(TM) liver fibrosis blood-serum test panel may help physicians more accurately diagnose and stage liver fibrosis in patients with chronic hepatitis C (HCV), potentially alleviating the need for liver biopsy, the standard of care for staging fibrosis, in a particular subset of patients. The Hepascore test panel is provided exclusively by Quest Diagnostics Incorporated (NYSE: DGX), the world"s leading provider of diagnostic testing, information and services.
Nutrition

Health Reform Price Tag Has Dems Scrambling To Lower Cost

The up to $1.6 trillion price tag for one version of health care reform has left Democrats scrambling to find a way to rein in costs while not sacrificing the basic tenets of a plan they favor, The Washington Post reports. The Congressional Budget Office said Tuesday that the President"s plan for health reform is likely to force the United States further into debt unless politically touchy changes - such as reducing payments to doctors and hospitals - are built into reform. "While popular measures such as increasing preventive care, expanding the use of electronic medical records and rewarding doctors for choosing more effective treatments have the potential to lower costs, "little reliable evidence exists about exactly how to implement those types of changes," Congressional Budget Office Director Douglas W. Elmendorf said in a letter to Senate budget leaders." Also, the CBO suggested "significantly limiting" the tax-free status of employer-provided health coverage. The White House is opposed to that idea, though it is popular among Democrats in the Senate (Montgomery, Murray and Connolly, 6/17). CBS News reports a key question asked by Sen. John McCain, R-Ariz., and other Republicans, "How are we going to pay for that, Mr. President?" CBS goes on to say that one question "how the nation really pays for health reform - just got a shocking wake up call." Though Democrats termed the CBO numbers "inconclusive" and the CBO itself said its report was "incomplete," the "magnitude of what Congress is considering" has become "undeniable." Rep. Eric Cantor, R-Va., told CBS: "The news yesterday from the CBO is a turning point in the health-care debate" (Andrews, 6/16). Meanwhile, a Senate Finance Committee bill score is due from the CBO and Sen. Max Baucus, D-Mont., chairman of the Finance Committee, gathered with Republican colleagues ahead of the score"s release, The New York Times reports. "The rush to trim costs came as Senate Democrats and the White House struggled to respond to an initial financial analysis by the budget office showing that an alternate proposal, developed by the Senate health committee, would cost $1 trillion over 10 years but could still leave 36 million Americans uninsured." The Times reported that the CBO analysis found the health committee Democrats falling short of their goal, "which is to provide insurance to all Americans and offset the expense of doing so with new taxes or cost savings." The study also "provided ammunition to critics, including the Republican leader, Senator Mitch McConnell of Kentucky. "The health care proposal being put together is not only extremely defective, it will cost a fortune," he said" (Herszenhorn and Pear, 6/16). This information was reprinted from kaiserhealthnews.org with kind permission from the Henry J. Kaiser Family Foundation. You can view the entire Kaiser Daily Health Policy Report, search the archives and sign up for email delivery at kaiserhealthnews.org. © Henry J. Kaiser Family Foundation. All rights reserved.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):